Trial intelligence / Profile preview

Oral Eubacterium hallii added to metformin for postprandial glucose control in men with type 2 diabetes

NL-OMON28536Recruiting

Sponsor
Amsterdam UMC
Start
Jan 2019
Countries
1
01

Overview

Trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Amsterdam UMC. Started Jan 2019; status: recruiting.

02

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NL-OMON28536.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28536.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call